Song, Y., Magenau, J., Li, Y., Braun, T., Chang, L., Bixby, D. L., . . . Choi, S. W. (2015). FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.
Chicago-viite (17. p.)Song, Yan, et al. FLT3 Mutational Status Is an Independent Risk Factor for Adverse Outcomes After Allogeneic Transplantation in AML. 2015.
MLA-viite (9. p.)Song, Yan, et al. FLT3 Mutational Status Is an Independent Risk Factor for Adverse Outcomes After Allogeneic Transplantation in AML. 2015.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.